{"ticker": {"uuid": "fecd5a07-7169-4241-a463-50edea07edcb", "symbol": "NMTC", "name": "Neuroone Medical Technologies Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxORk9ENlh5SlJsMWUxNEQxVlpSRENmeGxhU0hUdE02bERwWWZRSEZTeWRKZ1BuREhJOUppdTVnV0VjZ0tibGRpa0lzR1h4OXJNM1ZQdjA1YXVJbkZnd3N6U2xGX3hjaFVESWp5RWpQN2tOVG96ZnpCMUhZd0hha3NMZ3Z0Z1pEbHNpM2ZVSEFQQUVIQjFVTGNUUmlFNXhBQ3pmWWl3ODV5V29FeVdIVmNUMnJfN2xKTm9hQ3RGSTFqeEhIVGtrU3c?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T17:35:02+00:00", "published_display": "17 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neuroone-r-expands-drug-delivery-123000418.html", "source_name": "NewMediaWire", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Brian Pratt reports 1,085,934 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxObUFyMXJwSmxpUmlNemNyN0NCYzNjS1phUUJlLVNrUzVQLXcyZ1p1d3ZPS3RJR3d3ZWZmX0ZLNllnV0otV1ZnY3UyNDAwdGhtbDBEVXVMTXVjVDlkZ2pFZXJKYUFhQTltcDBQZnBtWXN6UTNrYUdnT2diYzFXOUJZa2ZhRmxnbDZJY0Nsa1EyeUtUQzEyM3B1VWduamhySFliMXdCay1sdG56ZUdXTFVfcElsX05pY2lfTkktVFdidjc3X3J5N3Z0dUdZSQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:28:33+00:00", "published_display": "14 Jul 2026 20:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC)", "summary": "Brian and Barbara Pratt have disclosed a beneficial ownership of 1,085,934 common shares in NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), representing 12.5% of the company's outstanding shares. This stake is held in a joint account, granting them shared voting and dis", "url": "https://www.stocktitan.net/sec-filings/NMTC/schedule-13g-a-neuroone-medical-technologies-corp-amended-passive-inv-c90413f9f13a.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:11:32", "published_display": "14 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June By Investing.com", "summary": "This article announces the filing of Form 144 by NEUROONE MEDICAL TECHNOLOGIES Corp for June 30. It is a very brief news item, primarily serving as a notification rather than providing detailed analysis. The article includes standard financial market data and popular news links c", "url": "https://ng.investing.com/news/stock-market-news/form-144-neuroone-medical-technologies-corp-for-30-june-93CH-2580280", "source_name": "Investing.com Nigeria", "published_at": "2026-07-03T18:39:16", "published_display": "03 Jul 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Mark Christianson Sells 10,000 Shares of NeuroOne Medical Technologies Corp (NMTC)", "summary": "Mark Christianson, Market Development Director at NeuroOne Medical Technologies Corp (NMTC), sold 10,000 shares of the company on June 30, 2026, reducing his holding to 20,692 shares. Over the past year, Christianson has sold a total of 70,000 shares with no purchases. NMTC share", "url": "https://www.gurufocus.com/news/8943770/insider-sell-mark-christianson-sells-10000-shares-of-neuroone-medical-technologies-corp-nmtc", "source_name": "GuruFocus", "published_at": "2026-07-03T07:09:38", "published_display": "03 Jul 2026 07:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC (NMTC) director sells 10,000 shares, retains 20,692 after trade", "summary": "Mark Christianson, the Market Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 10,000 shares of common stock at an average price of $3.1773 per share. Following this open-market transaction, he still directly holds 20,692 shares, indicating a continued, sub", "url": "https://www.stocktitan.net/sec-filings/NMTC/form-4-neuroone-medical-technologies-corp-insider-trading-activity-a1159619b7fa.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:09:38", "published_display": "02 Jul 2026 21:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Weighs on Support After 4.58% Decline - Sign of Strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNNmdYZVF3NldNMVB1SS14cy0wN1oxdHQ0c0s0cXJoWjBtcC1neVFFNlctcjlwMXI5c19seE80bVRGb3BIOVdiTEFGTFoyMUh0c1ZOaGNFbGpKUTdpV0M2NzAzQ3E1YXQwUTNBRmZtbnZWN1FBTGhKQ0JiT0VNam5NRmhyZ25vM1hiSGNBZGNJSkVJZ3MzLXg4ajNTY3NuNWNoTkh3X1VEOTRiVmRVRWt3VQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-30T16:46:26+00:00", "published_display": "30 Jun 2026 16:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] NEUROONE MEDICAL TECHNOLOGIES Corp SEC Filing", "summary": "Mark A. Christianson has filed a Form 144 to sell up to 10,000 shares of NeuroOne Medical Technologies Corp. common stock, valued at an aggregate of $33,400. The filing also documents previous sales in March 2026, totaling 30,692 shares acquired via award on April 20, 2026. This ", "url": "https://www.stocktitan.net/sec-filings/NMTC/144-neuroone-medical-technologies-corp-sec-filing-e61bcd7bc417.html", "source_name": "Stock Titan", "published_at": "2026-06-30T13:09:24", "published_display": "30 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Added to Russell Microcap(R) Index", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/neuroone-r-added-russell-microcap-123000583.html", "source_name": "NewMediaWire", "published_at": "2026-06-29T12:30:00+00:00", "published_display": "29 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell 3000E Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNLUU1Q0dkdzlETnE2blliTmRyWnZBLWI4VWtWQmhEaExReVp6LTdBRGoyM2J4dTd2QW8yLVM4SmkzWjhobzNOVV9jYmk0UjNiVFhBNUcwMmxGa0M3b1dtd21TY3NVblpVVDNfTmZrbUswdWdUS0loVWFncUdFeHJkWW9YQ0pyVWlRU1N0OXNHaXlrZXJFallDbnJOc2cwNVd1ZFduemltOG5yc3kxenA4MnpxdElOUE1yaXdQS3lLSjVJT3F4RENkWDEyUmtUWlcwV1gzekxjVnY5ZkF3dmVGZXNR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-29T08:12:59+00:00", "published_display": "29 Jun 2026 08:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form DEF 14A Neuroone Medical Technologies Corp For: 26 June By Investing.com", "summary": "This article reports on the filing of Form DEF 14A by Neuroone Medical Technologies Corp for June 26. It mentions the company's stock symbol NMTC, which showed a 4.38% increase. The piece provides a brief financial update on the company.", "url": "https://ca.investing.com/news/stock-market-news/form-def-14a-neuroone-medical-technologies-corp-for-26-june-93CH-4710212", "source_name": "Investing.com Canada", "published_at": "2026-06-27T22:09:56", "published_display": "27 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)", "summary": "NeuroOne Medical Technologies Corporation announced an equity award grant under its 2021 Inducement Plan to a new employee, effective June 24, 2026. This grant, in compliance with Nasdaq Listing Rule 5635(c)(4), is an option to purchase 10,000 shares of common stock with an exerc", "url": "https://finance.yahoo.com/healthcare/articles/neuroone-r-reports-inducement-grant-210000986.html", "source_name": "Market source", "published_at": "2026-06-26T02:40:28", "published_display": "26 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC Should I Buy", "summary": "NeuroOne Medical Technologies Corp (NMTC) is not recommended as a strong buy for long-term investors due to bearish technical indicators, lack of recent positive news, and absence of strong proprietary trading signals. While a recent analyst rating from Ladenburg increased the pr", "url": "https://intellectia.ai/en/stock/NMTC/should-i-buy", "source_name": "Intellectia AI", "published_at": "2026-06-22T11:40:19", "published_display": "22 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of NeuroOne Medical Technologies Corp (NMTC), noting its current valuation score of 9.50 and a P/E ratio of -1.11. The company ranks 12th out of 203 in the Healthcare Equipment & Supplies industry. Key valuation metrics like P/B, P/S, an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T22:40:08", "published_display": "18 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Institutional Confidence", "summary": "The article provides an analysis of NeuroOne Medical Technologies Corp (NMTC) institutional confidence score, which currently stands at 3.00, ranking it 132 out of 203 in the Healthcare Equipment & Supplies industry. It highlights that the institutional shareholding proportion is", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T22:10:33", "published_display": "18 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for NeuroOne Medical Technologies Corp (NMTC), indicating a current earnings forecast score of 8.67, ranking 16th in its industry. Analysts have a \"Buy\" rating for NMTC with an average target price of $2.23. The company's expected revenu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:13", "published_display": "18 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp", "summary": "This article from TradingKey provides an overview of NeuroOne Medical Technologies Corp (NMTC), including its stock performance and market capitalization. The main point of the article's content regarding revenue breakdown by business segment and region is that relevant data has ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T22:40:13", "published_display": "17 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of NeuroOne Medical Technologies Corp's (NMTC) dividend and stock split history. It indicates that NMTC has not distributed any dividends over the past five years. However, it notes a stock split event scheduled for April 14, 2026, which is a 6-t", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T22:40:13", "published_display": "17 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index", "summary": "NeuroOne Medical Technologies Corporation (NMTC) is expected to join the Russell Microcap\u00ae Index following the first semi-annual 2026 Russell indexes reconstitution. The company anticipates this inclusion will enhance its visibility among institutional investors and broaden its s", "url": "https://finance.yahoo.com/markets/stocks/articles/neuroone-r-announces-preliminary-inclusion-123000527.html", "source_name": "Market source", "published_at": "2026-06-16T12:09:36", "published_display": "16 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne to sell up to $13.4M in common stock through updated ATM prospectus", "summary": "NeuroOne (NMTC) has filed an updated prospectus to offer up to $13.4 million of common stock through its existing At-The-Market (ATM) program. The shares will be sold via JonesTrading under a Capital on Demand\u2122 Sales Agreement, allowing the company to raise capital as needed. Thi", "url": "https://www.tradingview.com/news/tradingview:d9177fb421644:0-neuroone-to-sell-up-to-13-4m-in-common-stock-through-updated-atm-prospectus/", "source_name": "TradingView", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne (NASDAQ: NMTC) ups at\u2011the\u2011market capacity to $13.4M via JonesTrading", "summary": "NeuroOne Medical Technologies Corporation has increased its at-the-market (ATM) sales agreement capacity with JonesTrading to $13.4 million. This supplement allows for additional common stock sales, leveraging an existing agreement from December 2022. The company had previously s", "url": "https://www.stocktitan.net/sec-filings/NMTC/424b5-neuroone-medical-technologies-corp-prospectus-supplement-debt-s-e1d6fa0d996e.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) refreshes $13.4M at-the-market share offering", "summary": "NeuroOne Medical Technologies (NMTC) has refreshed its at-the-market (ATM) stock offering, allowing it to sell up to $13.4 million in common shares through JonesTrading. This update, filed via a Prospectus Supplement on June 12, 2026, uses an existing Capital on Demand Sales Agre", "url": "https://www.stocktitan.net/sec-filings/NMTC/8-k-neuroone-medical-technologies-corp-reports-material-event-5919ba95ed39.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical (NASDAQ: NMTC) restates revenue and warns on going concern", "summary": "NeuroOne Medical Technologies Corporation has restated its Q2 2026 financial results due to duplicated revenue and cost entries, leading to a reduction in product revenue and gross profit. The company reported a significant net loss and reiterated substantial doubt about its abil", "url": "https://www.stocktitan.net/sec-filings/NMTC/10-q-a-neuroone-medical-technologies-corp-amended-quarterly-earnings--e5d5c89c6232.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 15, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time", "summary": "NeuroOne Medical Technologies Corporation announced its participation in the Planet MicroCap Las Vegas 2026 Conference. Dave Rosa, President & CEO, will host one-on-one meetings with institutional investors and deliver a presentation on June 17, 2026, detailing commercialization ", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-r-present-planet-microcap-123000769.html", "source_name": "Market source", "published_at": "2026-06-11T12:40:08", "published_display": "11 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices Specialty Stocks Q1 2026: Enovis Revenue Beat, Stock Down 12% - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOdnZ5WlFjVTNFcV9PbG5zY3FMcVg4Y0RvVklPdXJRbC01Y3BvWVRYNmphaXBHdU5HajktbnNkX2JCbU9HYzdON2NmTTgzNVZkU3ZkOG95RE9lRkRNQW90OUdqRFJUajIzQVFZSGMtYUxsVlUxUUZkNWdvNjMxby1aS1JkZXN4eGZEM0tiOTJubw?oc=5", "source_name": "IndexBox", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Highlights: CooperCompanies (NASDAQ:COO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNN1hOQW5NYmtjUWRLcFdNUmFSOEtxN1NEUHVZdmVCaW5nRGdlYjFxbEJySFVRczltT1BYQkR6clNNYUFuRE9mTllDLUtSUE9RUzZfbVktdnFKUU5oVFJnYktGbWlSUEZwS3lYejl4Mkp2VDBZMFRFOUNsdmZhLUxfZXdLTU01N3VIMlBNM1Y3Ym13LWhlY0lJTmFQUXlockRjUk16alFtblpXV2VITkpOOUdn?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (Nasdaq:NMTC) - Stock Analysis", "summary": "NeuroOne Medical Technologies (NMTC) is a medical technology company focusing on solutions for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording. The stock is currently trading significantly below its estimated fair value, but analysts proje", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-nmtc/neuroone-medical-technologies", "source_name": "Simply Wall Street", "published_at": "2026-05-31T15:39:43", "published_display": "31 May 2026 15:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC - NeuroOne Medical Technologies Corp Stock Price and Quote", "summary": "This article provides a comprehensive overview of NeuroOne Medical Technologies Corp (NMTC), including its stock price, financial metrics, analyst ratings, performance history, and recent news. It highlights the company's inclusion in the Russell Microcap Index and details signif", "url": "https://finviz.com/stock?t=NMTC", "source_name": "Finviz", "published_at": "2026-05-30T15:09:24", "published_display": "30 May 2026 15:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC - NeuroOne Medical Technologies Corporation stock news, filings & ratings", "summary": "NeuroOne Medical Technologies Corporation (NMTC) operates as a medical technology company specializing in thin-film electrode technology for various neurological disorders. The company's stock is currently trading at $3.55, down 4.70%, and it has recently seen several SEC filings", "url": "https://quantisnow.com/company/NMTC", "source_name": "Quantisnow", "published_at": "2026-05-30T01:09:29", "published_display": "30 May 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-r-present-2026-american-123000457.html", "source_name": "NewMediaWire", "published_at": "2026-05-28T12:30:00+00:00", "published_display": "28 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Edges Higher as Stock Holds Above Key Support - Sector ETF Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWF9EalZ1ajlLdE1iN2wyM0pVMENTemdSMDl4c183RFR2WVZpOXAzdllJS1ZrTWpSaWtfTXhoVnp5Vlk0d2ljN1ZlR1FPTnNfNXFkWUVvdksxXzVjU0lkZnFTY1lNQWM0dXAteTNMNmNPRjJhTUVOWGZJdGZNZkxRTFhDaFpkbmdxZUh0MnRmbUM2VG84XzkwSjdHUGw4WHg5ZWZjSjljT0tyZzIxdE9Wc2ZJZUlFMHptSnJ5OWZ4LW5pUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Edges Higher as Stock Holds Above Key Support - Breakaway Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQVkx6MjF2LTBwYzhkSHJ0M20yNUc2YU1OYWZFcHR5M3RoejNiQWVPdHFQeV80WTJTclFWcW5tUERZZXM0ZTVROHBkR2pobk1pX2lzbU1LVFdmN25FbW5LdG9jV2xBQ2VndENWdFg3anFiUmtjd2RpRGxQb21PNmY5UjVZNkRCdFlXMU10cXliT2hsaS13NjdDeVFtTEdMNmhqT0lNMnVJQU93MW5GaWVPV1RYclB1MGRoUHV3bGFvZjN4emc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies to Restate Q1 2026 Financials After Revenue Overstatement; Reaffirms $10.5M FY2026 Guidance", "summary": "NeuroOne Medical Technologies will restate its Q1 2026 financial results due to a revenue recognition error that caused a $0.5 million overstatement. The restatement will impact gross profit and net loss figures for the quarter. Despite this, the company reaffirms its fiscal year", "url": "https://www.minichart.com.sg/2026/05/23/neuroone-medical-technologies-to-restate-q1-2026-financials-after-revenue-overstatement-reaffirms-10-5m-fy2026-guidance/", "source_name": "Minichart", "published_at": "2026-05-23T11:41:15", "published_display": "23 May 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "According to documents submitted by NEUROONE MEDICAL TECH to the U.S. Securities and Exchange Commission, the company has restated its financial data for the first quarter of 2026 to correct a previous overstatement of revenue by approximately $50", "summary": "NEUROONE MEDICAL TECH has restated its financial data for the first quarter of 2026, correcting an overstatement of revenue by approximately $500,000. This action, submitted to the U.S. Securities and Exchange Commission, aims to ensure accuracy and compliance. Investors are advi", "url": "https://www.bitget.com/amp/news/detail/12560605424472", "source_name": "Bitget", "published_at": "2026-05-22T21:39:02", "published_display": "22 May 2026 21:39", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-r-medical-technologies-announces-203000198.html", "source_name": "NewMediaWire", "published_at": "2026-05-22T20:30:00+00:00", "published_display": "22 May 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne (Nasdaq: NMTC) to restate March 31 2026 results, keeps guidance", "summary": "NeuroOne Medical Technologies (Nasdaq: NMTC) announced it will restate its interim financial statements for the quarter ended March 31, 2026, due to revenue-recognition errors related to modified customer purchase orders. The company identified an overstatement of revenue by appr", "url": "https://www.stocktitan.net/sec-filings/NMTC/8-k-neuroone-medical-technologies-corp-reports-material-event-4eefeefa62e7.html", "source_name": "Stock Titan", "published_at": "2026-05-22T20:12:14", "published_display": "22 May 2026 20:12", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises By Investing.com", "summary": "NeuroOne Medical Technologies Corporation reported Q2 FY2026 earnings per share and revenue below analyst forecasts, with an EPS of -$0.25 against -$0.22 expected and revenue of $2.4 million versus $2.58 million. Despite these misses, the company's stock rose by 4.16% due to stro", "url": "https://m.za.investing.com/news/stock-market-news/earnings-call-transcript-neuroone-misses-q2-2026-forecasts-stock-rises-93CH-4287717?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-05-18T20:40:32", "published_display": "18 May 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ...", "summary": "", "url": "https://finance.yahoo.com/news/neuroone-medical-technologies-corp-nmtc-230251862.html", "source_name": "GuruFocus.com", "published_at": "2026-05-12T23:02:51+00:00", "published_display": "12 May 2026 23:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-reports-fiscal-q2-2026-120000984.html", "source_name": "NewMediaWire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxON0JTR2VfbnVEVTM5dkFDMHZpcHNvRjdkRFB1MGVIeWVhWHcwb181aG84S0RXVXJpWUtleHZiQkhvbFl5dlBiOHZDNFNqRUxzR1FtbW9yWUtJNGxXLV96X2xIVmpJUlotdDJ3RExRUmQ3bkJKZXNKTFZqM3pCaWs0ZDRub0c4YzZVZjZWWGIxTTFVdzNBcTBveHl4SlJlTUNrZ0lVVDNyQzdEZ0EyRkJERGpqX3U3MFdMV2hWeFpDVVJMemh2Yk93eENkbEZ6MFhUYWNCaE1MTWllektUUjVvZWlJU21KQ1k?oc=5", "source_name": "ChartMill", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Report Preview: What to Look For", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-medical-technologies-corp-nmtc-132344366.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T13:23:44+00:00", "published_display": "11 May 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVHhPY3NEcEFMWjZWYzFhYkpLcVVwenk3cUZFbGVqN2VoX3VXSHlmVUJJZHJ3a3pLcGVrWUlaZnNkLVI1MjdfTGZ3dTVwc01JNGpnX1h1MTJWYVc3OXZZcXhWU2VtUWxlbzBGa2k0Y1JiS1hrZGkySzY3dmp6X216bHNiSmtUa0dMbkVsUnNiNUQ3d2hONGF0Q1p5MHFYUGUzaUs2MFNkTEZzUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies announces 1-for-6 reverse stock split", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOMnduVUVjU3hxZk9rU3dxUU40UWRyXzBsWDB3Z1NBWm1BVHI0Q2tpTzdCeG44Mzk3NjBTc1pCVTRsUGJVUW54ZTlCM1NxMWNMQ2dINm1TVDdpOFNISFRuWXlzY3U0UU02VmxlQUpZMWROc3BXckk3ZngxaEpTRU05YzBsTEl1QUJORURQNTZLMFV2akwyOHRPS1phOXBvcVRlR0NmUzZhbEFUd1NBaHk2QThJbVZzTFU2MHp2a0t3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bullish NeuroOne Medical Technologies Insiders Rewarded As Their Investment Rises To US$829.9k", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNZkhJRWo4VS1DcFcxWXRvdTN4US1zdklfX2xTYVBVeHFvNTUxQ1ktVFFEMFFOQVNSWEkxcUVnc0E1bXh5R0pnMGJlOURpOWtvVzhNcXlYYXZCVDczYks4Wkd0QmIwbXI1cHVsWDhUS1UzM01DR3FYSG1vaTFsWFU4NUlsTC1JWktXcVBsMnkxVkVWR3R0Wm5fMmRWNG5HZDVFVTNwTjI1bW15MHpRNW1Ca3NIZzZxRzlMU1laSERDTUVHZ1NabkRhYm1LR2hUeGVWZi11cW9EU3lhOFc0UWxWeERBS2_SAeoBQVVfeXFMUHBUdjh4WklENmFHLVA5R0VaczhCRDdneTUwb0F5X2tMS3VjX1hidXNOd2pvQzFPSGp3eFBlU3gtNkw5aHBzMFZiZ0VtNDc5dk4zc2xlVS1DZHNUdnFtZkpXZjhLS3gyUGxtUklyVVJ0Y2NGYVF1aGotcGxCbUlpd05BdmN0ZHQtUm9YTlY1NWdYQTNPYlBCb1RuR25naU10UFg3d1E1SjFSVHFJVnVPYmI5cVctN3N0UmZHZHh4RFlLS3hua2N1RmJtdXBGUEZsalE2QkRjV244RTdPbWREWEtmSHFMRVR5ZENB?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOd1pNRFRBVUF2RG5RNWNhSVJaWFM5aUFRVF9xSF8zVHVMcVBoSXdaRXJrbV8wLUFOS2tHOHIzZEhZSF9rZ2dVbVNIOEdEbE9GMmpsMEtIUE9OTGRjcUlyVnNSa2FyX3hjcmF2YTNDOGQ1UDVjMHI4ak44bUl1bnVoQ3VfSjZGMXR5T19xOWkzaUtSZ2NiMF80bUtvVWU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxORk9ENlh5SlJsMWUxNEQxVlpSRENmeGxhU0hUdE02bERwWWZRSEZTeWRKZ1BuREhJOUppdTVnV0VjZ0tibGRpa0lzR1h4OXJNM1ZQdjA1YXVJbkZnd3N6U2xGX3hjaFVESWp5RWpQN2tOVG96ZnpCMUhZd0hha3NMZ3Z0Z1pEbHNpM2ZVSEFQQUVIQjFVTGNUUmlFNXhBQ3pmWWl3ODV5V29FeVdIVmNUMnJfN2xKTm9hQ3RGSTFqeEhIVGtrU3c?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T17:35:02+00:00", "published_display": "17 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neuroone-r-expands-drug-delivery-123000418.html", "source_name": "NewMediaWire", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Brian Pratt reports 1,085,934 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxObUFyMXJwSmxpUmlNemNyN0NCYzNjS1phUUJlLVNrUzVQLXcyZ1p1d3ZPS3RJR3d3ZWZmX0ZLNllnV0otV1ZnY3UyNDAwdGhtbDBEVXVMTXVjVDlkZ2pFZXJKYUFhQTltcDBQZnBtWXN6UTNrYUdnT2diYzFXOUJZa2ZhRmxnbDZJY0Nsa1EyeUtUQzEyM3B1VWduamhySFliMXdCay1sdG56ZUdXTFVfcElsX05pY2lfTkktVFdidjc3X3J5N3Z0dUdZSQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:28:33+00:00", "published_display": "14 Jul 2026 20:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC)", "summary": "Brian and Barbara Pratt have disclosed a beneficial ownership of 1,085,934 common shares in NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), representing 12.5% of the company's outstanding shares. This stake is held in a joint account, granting them shared voting and dis", "url": "https://www.stocktitan.net/sec-filings/NMTC/schedule-13g-a-neuroone-medical-technologies-corp-amended-passive-inv-c90413f9f13a.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:11:32", "published_display": "14 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June By Investing.com", "summary": "This article announces the filing of Form 144 by NEUROONE MEDICAL TECHNOLOGIES Corp for June 30. It is a very brief news item, primarily serving as a notification rather than providing detailed analysis. The article includes standard financial market data and popular news links c", "url": "https://ng.investing.com/news/stock-market-news/form-144-neuroone-medical-technologies-corp-for-30-june-93CH-2580280", "source_name": "Investing.com Nigeria", "published_at": "2026-07-03T18:39:16", "published_display": "03 Jul 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Mark Christianson Sells 10,000 Shares of NeuroOne Medical Technologies Corp (NMTC)", "summary": "Mark Christianson, Market Development Director at NeuroOne Medical Technologies Corp (NMTC), sold 10,000 shares of the company on June 30, 2026, reducing his holding to 20,692 shares. Over the past year, Christianson has sold a total of 70,000 shares with no purchases. NMTC share", "url": "https://www.gurufocus.com/news/8943770/insider-sell-mark-christianson-sells-10000-shares-of-neuroone-medical-technologies-corp-nmtc", "source_name": "GuruFocus", "published_at": "2026-07-03T07:09:38", "published_display": "03 Jul 2026 07:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC (NMTC) director sells 10,000 shares, retains 20,692 after trade", "summary": "Mark Christianson, the Market Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 10,000 shares of common stock at an average price of $3.1773 per share. Following this open-market transaction, he still directly holds 20,692 shares, indicating a continued, sub", "url": "https://www.stocktitan.net/sec-filings/NMTC/form-4-neuroone-medical-technologies-corp-insider-trading-activity-a1159619b7fa.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:09:38", "published_display": "02 Jul 2026 21:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Weighs on Support After 4.58% Decline - Sign of Strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNNmdYZVF3NldNMVB1SS14cy0wN1oxdHQ0c0s0cXJoWjBtcC1neVFFNlctcjlwMXI5c19seE80bVRGb3BIOVdiTEFGTFoyMUh0c1ZOaGNFbGpKUTdpV0M2NzAzQ3E1YXQwUTNBRmZtbnZWN1FBTGhKQ0JiT0VNam5NRmhyZ25vM1hiSGNBZGNJSkVJZ3MzLXg4ajNTY3NuNWNoTkh3X1VEOTRiVmRVRWt3VQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-30T16:46:26+00:00", "published_display": "30 Jun 2026 16:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] NEUROONE MEDICAL TECHNOLOGIES Corp SEC Filing", "summary": "Mark A. Christianson has filed a Form 144 to sell up to 10,000 shares of NeuroOne Medical Technologies Corp. common stock, valued at an aggregate of $33,400. The filing also documents previous sales in March 2026, totaling 30,692 shares acquired via award on April 20, 2026. This ", "url": "https://www.stocktitan.net/sec-filings/NMTC/144-neuroone-medical-technologies-corp-sec-filing-e61bcd7bc417.html", "source_name": "Stock Titan", "published_at": "2026-06-30T13:09:24", "published_display": "30 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Added to Russell Microcap(R) Index", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/neuroone-r-added-russell-microcap-123000583.html", "source_name": "NewMediaWire", "published_at": "2026-06-29T12:30:00+00:00", "published_display": "29 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell 3000E Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNLUU1Q0dkdzlETnE2blliTmRyWnZBLWI4VWtWQmhEaExReVp6LTdBRGoyM2J4dTd2QW8yLVM4SmkzWjhobzNOVV9jYmk0UjNiVFhBNUcwMmxGa0M3b1dtd21TY3NVblpVVDNfTmZrbUswdWdUS0loVWFncUdFeHJkWW9YQ0pyVWlRU1N0OXNHaXlrZXJFallDbnJOc2cwNVd1ZFduemltOG5yc3kxenA4MnpxdElOUE1yaXdQS3lLSjVJT3F4RENkWDEyUmtUWlcwV1gzekxjVnY5ZkF3dmVGZXNR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-29T08:12:59+00:00", "published_display": "29 Jun 2026 08:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form DEF 14A Neuroone Medical Technologies Corp For: 26 June By Investing.com", "summary": "This article reports on the filing of Form DEF 14A by Neuroone Medical Technologies Corp for June 26. It mentions the company's stock symbol NMTC, which showed a 4.38% increase. The piece provides a brief financial update on the company.", "url": "https://ca.investing.com/news/stock-market-news/form-def-14a-neuroone-medical-technologies-corp-for-26-june-93CH-4710212", "source_name": "Investing.com Canada", "published_at": "2026-06-27T22:09:56", "published_display": "27 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)", "summary": "NeuroOne Medical Technologies Corporation announced an equity award grant under its 2021 Inducement Plan to a new employee, effective June 24, 2026. This grant, in compliance with Nasdaq Listing Rule 5635(c)(4), is an option to purchase 10,000 shares of common stock with an exerc", "url": "https://finance.yahoo.com/healthcare/articles/neuroone-r-reports-inducement-grant-210000986.html", "source_name": "Market source", "published_at": "2026-06-26T02:40:28", "published_display": "26 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC Should I Buy", "summary": "NeuroOne Medical Technologies Corp (NMTC) is not recommended as a strong buy for long-term investors due to bearish technical indicators, lack of recent positive news, and absence of strong proprietary trading signals. While a recent analyst rating from Ladenburg increased the pr", "url": "https://intellectia.ai/en/stock/NMTC/should-i-buy", "source_name": "Intellectia AI", "published_at": "2026-06-22T11:40:19", "published_display": "22 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of NeuroOne Medical Technologies Corp (NMTC), noting its current valuation score of 9.50 and a P/E ratio of -1.11. The company ranks 12th out of 203 in the Healthcare Equipment & Supplies industry. Key valuation metrics like P/B, P/S, an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T22:40:08", "published_display": "18 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Institutional Confidence", "summary": "The article provides an analysis of NeuroOne Medical Technologies Corp (NMTC) institutional confidence score, which currently stands at 3.00, ranking it 132 out of 203 in the Healthcare Equipment & Supplies industry. It highlights that the institutional shareholding proportion is", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T22:10:33", "published_display": "18 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for NeuroOne Medical Technologies Corp (NMTC), indicating a current earnings forecast score of 8.67, ranking 16th in its industry. Analysts have a \"Buy\" rating for NMTC with an average target price of $2.23. The company's expected revenu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:13", "published_display": "18 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp", "summary": "This article from TradingKey provides an overview of NeuroOne Medical Technologies Corp (NMTC), including its stock performance and market capitalization. The main point of the article's content regarding revenue breakdown by business segment and region is that relevant data has ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T22:40:13", "published_display": "17 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of NeuroOne Medical Technologies Corp's (NMTC) dividend and stock split history. It indicates that NMTC has not distributed any dividends over the past five years. However, it notes a stock split event scheduled for April 14, 2026, which is a 6-t", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nmtc/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T22:40:13", "published_display": "17 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index", "summary": "NeuroOne Medical Technologies Corporation (NMTC) is expected to join the Russell Microcap\u00ae Index following the first semi-annual 2026 Russell indexes reconstitution. The company anticipates this inclusion will enhance its visibility among institutional investors and broaden its s", "url": "https://finance.yahoo.com/markets/stocks/articles/neuroone-r-announces-preliminary-inclusion-123000527.html", "source_name": "Market source", "published_at": "2026-06-16T12:09:36", "published_display": "16 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne to sell up to $13.4M in common stock through updated ATM prospectus", "summary": "NeuroOne (NMTC) has filed an updated prospectus to offer up to $13.4 million of common stock through its existing At-The-Market (ATM) program. The shares will be sold via JonesTrading under a Capital on Demand\u2122 Sales Agreement, allowing the company to raise capital as needed. Thi", "url": "https://www.tradingview.com/news/tradingview:d9177fb421644:0-neuroone-to-sell-up-to-13-4m-in-common-stock-through-updated-atm-prospectus/", "source_name": "TradingView", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne (NASDAQ: NMTC) ups at\u2011the\u2011market capacity to $13.4M via JonesTrading", "summary": "NeuroOne Medical Technologies Corporation has increased its at-the-market (ATM) sales agreement capacity with JonesTrading to $13.4 million. This supplement allows for additional common stock sales, leveraging an existing agreement from December 2022. The company had previously s", "url": "https://www.stocktitan.net/sec-filings/NMTC/424b5-neuroone-medical-technologies-corp-prospectus-supplement-debt-s-e1d6fa0d996e.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) refreshes $13.4M at-the-market share offering", "summary": "NeuroOne Medical Technologies (NMTC) has refreshed its at-the-market (ATM) stock offering, allowing it to sell up to $13.4 million in common shares through JonesTrading. This update, filed via a Prospectus Supplement on June 12, 2026, uses an existing Capital on Demand Sales Agre", "url": "https://www.stocktitan.net/sec-filings/NMTC/8-k-neuroone-medical-technologies-corp-reports-material-event-5919ba95ed39.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical (NASDAQ: NMTC) restates revenue and warns on going concern", "summary": "NeuroOne Medical Technologies Corporation has restated its Q2 2026 financial results due to duplicated revenue and cost entries, leading to a reduction in product revenue and gross profit. The company reported a significant net loss and reiterated substantial doubt about its abil", "url": "https://www.stocktitan.net/sec-filings/NMTC/10-q-a-neuroone-medical-technologies-corp-amended-quarterly-earnings--e5d5c89c6232.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:39:14", "published_display": "12 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 15, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time", "summary": "NeuroOne Medical Technologies Corporation announced its participation in the Planet MicroCap Las Vegas 2026 Conference. Dave Rosa, President & CEO, will host one-on-one meetings with institutional investors and deliver a presentation on June 17, 2026, detailing commercialization ", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-r-present-planet-microcap-123000769.html", "source_name": "Market source", "published_at": "2026-06-11T12:40:08", "published_display": "11 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices Specialty Stocks Q1 2026: Enovis Revenue Beat, Stock Down 12% - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOdnZ5WlFjVTNFcV9PbG5zY3FMcVg4Y0RvVklPdXJRbC01Y3BvWVRYNmphaXBHdU5HajktbnNkX2JCbU9HYzdON2NmTTgzNVZkU3ZkOG95RE9lRkRNQW90OUdqRFJUajIzQVFZSGMtYUxsVlUxUUZkNWdvNjMxby1aS1JkZXN4eGZEM0tiOTJubw?oc=5", "source_name": "IndexBox", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Highlights: CooperCompanies (NASDAQ:COO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNN1hOQW5NYmtjUWRLcFdNUmFSOEtxN1NEUHVZdmVCaW5nRGdlYjFxbEJySFVRczltT1BYQkR6clNNYUFuRE9mTllDLUtSUE9RUzZfbVktdnFKUU5oVFJnYktGbWlSUEZwS3lYejl4Mkp2VDBZMFRFOUNsdmZhLUxfZXdLTU01N3VIMlBNM1Y3Ym13LWhlY0lJTmFQUXlockRjUk16alFtblpXV2VITkpOOUdn?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (Nasdaq:NMTC) - Stock Analysis", "summary": "NeuroOne Medical Technologies (NMTC) is a medical technology company focusing on solutions for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording. The stock is currently trading significantly below its estimated fair value, but analysts proje", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-nmtc/neuroone-medical-technologies", "source_name": "Simply Wall Street", "published_at": "2026-05-31T15:39:43", "published_display": "31 May 2026 15:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC - NeuroOne Medical Technologies Corp Stock Price and Quote", "summary": "This article provides a comprehensive overview of NeuroOne Medical Technologies Corp (NMTC), including its stock price, financial metrics, analyst ratings, performance history, and recent news. It highlights the company's inclusion in the Russell Microcap Index and details signif", "url": "https://finviz.com/stock?t=NMTC", "source_name": "Finviz", "published_at": "2026-05-30T15:09:24", "published_display": "30 May 2026 15:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NMTC - NeuroOne Medical Technologies Corporation stock news, filings & ratings", "summary": "NeuroOne Medical Technologies Corporation (NMTC) operates as a medical technology company specializing in thin-film electrode technology for various neurological disorders. The company's stock is currently trading at $3.55, down 4.70%, and it has recently seen several SEC filings", "url": "https://quantisnow.com/company/NMTC", "source_name": "Quantisnow", "published_at": "2026-05-30T01:09:29", "published_display": "30 May 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-r-present-2026-american-123000457.html", "source_name": "NewMediaWire", "published_at": "2026-05-28T12:30:00+00:00", "published_display": "28 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Edges Higher as Stock Holds Above Key Support - Sector ETF Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWF9EalZ1ajlLdE1iN2wyM0pVMENTemdSMDl4c183RFR2WVZpOXAzdllJS1ZrTWpSaWtfTXhoVnp5Vlk0d2ljN1ZlR1FPTnNfNXFkWUVvdksxXzVjU0lkZnFTY1lNQWM0dXAteTNMNmNPRjJhTUVOWGZJdGZNZkxRTFhDaFpkbmdxZUh0MnRmbUM2VG84XzkwSjdHUGw4WHg5ZWZjSjljT0tyZzIxdE9Wc2ZJZUlFMHptSnJ5OWZ4LW5pUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NMTC) Edges Higher as Stock Holds Above Key Support - Breakaway Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQVkx6MjF2LTBwYzhkSHJ0M20yNUc2YU1OYWZFcHR5M3RoejNiQWVPdHFQeV80WTJTclFWcW5tUERZZXM0ZTVROHBkR2pobk1pX2lzbU1LVFdmN25FbW5LdG9jV2xBQ2VndENWdFg3anFiUmtjd2RpRGxQb21PNmY5UjVZNkRCdFlXMU10cXliT2hsaS13NjdDeVFtTEdMNmhqT0lNMnVJQU93MW5GaWVPV1RYclB1MGRoUHV3bGFvZjN4emc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies to Restate Q1 2026 Financials After Revenue Overstatement; Reaffirms $10.5M FY2026 Guidance", "summary": "NeuroOne Medical Technologies will restate its Q1 2026 financial results due to a revenue recognition error that caused a $0.5 million overstatement. The restatement will impact gross profit and net loss figures for the quarter. Despite this, the company reaffirms its fiscal year", "url": "https://www.minichart.com.sg/2026/05/23/neuroone-medical-technologies-to-restate-q1-2026-financials-after-revenue-overstatement-reaffirms-10-5m-fy2026-guidance/", "source_name": "Minichart", "published_at": "2026-05-23T11:41:15", "published_display": "23 May 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "According to documents submitted by NEUROONE MEDICAL TECH to the U.S. Securities and Exchange Commission, the company has restated its financial data for the first quarter of 2026 to correct a previous overstatement of revenue by approximately $50", "summary": "NEUROONE MEDICAL TECH has restated its financial data for the first quarter of 2026, correcting an overstatement of revenue by approximately $500,000. This action, submitted to the U.S. Securities and Exchange Commission, aims to ensure accuracy and compliance. Investors are advi", "url": "https://www.bitget.com/amp/news/detail/12560605424472", "source_name": "Bitget", "published_at": "2026-05-22T21:39:02", "published_display": "22 May 2026 21:39", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-r-medical-technologies-announces-203000198.html", "source_name": "NewMediaWire", "published_at": "2026-05-22T20:30:00+00:00", "published_display": "22 May 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne (Nasdaq: NMTC) to restate March 31 2026 results, keeps guidance", "summary": "NeuroOne Medical Technologies (Nasdaq: NMTC) announced it will restate its interim financial statements for the quarter ended March 31, 2026, due to revenue-recognition errors related to modified customer purchase orders. The company identified an overstatement of revenue by appr", "url": "https://www.stocktitan.net/sec-filings/NMTC/8-k-neuroone-medical-technologies-corp-reports-material-event-4eefeefa62e7.html", "source_name": "Stock Titan", "published_at": "2026-05-22T20:12:14", "published_display": "22 May 2026 20:12", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises By Investing.com", "summary": "NeuroOne Medical Technologies Corporation reported Q2 FY2026 earnings per share and revenue below analyst forecasts, with an EPS of -$0.25 against -$0.22 expected and revenue of $2.4 million versus $2.58 million. Despite these misses, the company's stock rose by 4.16% due to stro", "url": "https://m.za.investing.com/news/stock-market-news/earnings-call-transcript-neuroone-misses-q2-2026-forecasts-stock-rises-93CH-4287717?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-05-18T20:40:32", "published_display": "18 May 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ...", "summary": "", "url": "https://finance.yahoo.com/news/neuroone-medical-technologies-corp-nmtc-230251862.html", "source_name": "GuruFocus.com", "published_at": "2026-05-12T23:02:51+00:00", "published_display": "12 May 2026 23:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-reports-fiscal-q2-2026-120000984.html", "source_name": "NewMediaWire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxON0JTR2VfbnVEVTM5dkFDMHZpcHNvRjdkRFB1MGVIeWVhWHcwb181aG84S0RXVXJpWUtleHZiQkhvbFl5dlBiOHZDNFNqRUxzR1FtbW9yWUtJNGxXLV96X2xIVmpJUlotdDJ3RExRUmQ3bkJKZXNKTFZqM3pCaWs0ZDRub0c4YzZVZjZWWGIxTTFVdzNBcTBveHl4SlJlTUNrZ0lVVDNyQzdEZ0EyRkJERGpqX3U3MFdMV2hWeFpDVVJMemh2Yk93eENkbEZ6MFhUYWNCaE1MTWllektUUjVvZWlJU21KQ1k?oc=5", "source_name": "ChartMill", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Report Preview: What to Look For", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuroone-medical-technologies-corp-nmtc-132344366.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T13:23:44+00:00", "published_display": "11 May 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVHhPY3NEcEFMWjZWYzFhYkpLcVVwenk3cUZFbGVqN2VoX3VXSHlmVUJJZHJ3a3pLcGVrWUlaZnNkLVI1MjdfTGZ3dTVwc01JNGpnX1h1MTJWYVc3OXZZcXhWU2VtUWxlbzBGa2k0Y1JiS1hrZGkySzY3dmp6X216bHNiSmtUa0dMbkVsUnNiNUQ3d2hONGF0Q1p5MHFYUGUzaUs2MFNkTEZzUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroOne Medical Technologies announces 1-for-6 reverse stock split", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOMnduVUVjU3hxZk9rU3dxUU40UWRyXzBsWDB3Z1NBWm1BVHI0Q2tpTzdCeG44Mzk3NjBTc1pCVTRsUGJVUW54ZTlCM1NxMWNMQ2dINm1TVDdpOFNISFRuWXlzY3U0UU02VmxlQUpZMWROc3BXckk3ZngxaEpTRU05YzBsTEl1QUJORURQNTZLMFV2akwyOHRPS1phOXBvcVRlR0NmUzZhbEFUd1NBaHk2QThJbVZzTFU2MHp2a0t3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bullish NeuroOne Medical Technologies Insiders Rewarded As Their Investment Rises To US$829.9k", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNZkhJRWo4VS1DcFcxWXRvdTN4US1zdklfX2xTYVBVeHFvNTUxQ1ktVFFEMFFOQVNSWEkxcUVnc0E1bXh5R0pnMGJlOURpOWtvVzhNcXlYYXZCVDczYks4Wkd0QmIwbXI1cHVsWDhUS1UzM01DR3FYSG1vaTFsWFU4NUlsTC1JWktXcVBsMnkxVkVWR3R0Wm5fMmRWNG5HZDVFVTNwTjI1bW15MHpRNW1Ca3NIZzZxRzlMU1laSERDTUVHZ1NabkRhYm1LR2hUeGVWZi11cW9EU3lhOFc0UWxWeERBS2_SAeoBQVVfeXFMUHBUdjh4WklENmFHLVA5R0VaczhCRDdneTUwb0F5X2tMS3VjX1hidXNOd2pvQzFPSGp3eFBlU3gtNkw5aHBzMFZiZ0VtNDc5dk4zc2xlVS1DZHNUdnFtZkpXZjhLS3gyUGxtUklyVVJ0Y2NGYVF1aGotcGxCbUlpd05BdmN0ZHQtUm9YTlY1NWdYQTNPYlBCb1RuR25naU10UFg3d1E1SjFSVHFJVnVPYmI5cVctN3N0UmZHZHh4RFlLS3hua2N1RmJtdXBGUEZsalE2QkRjV244RTdPbWREWEtmSHFMRVR5ZENB?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOd1pNRFRBVUF2RG5RNWNhSVJaWFM5aUFRVF9xSF8zVHVMcVBoSXdaRXJrbV8wLUFOS2tHOHIzZEhZSF9rZ2dVbVNIOEdEbE9GMmpsMEtIUE9OTGRjcUlyVnNSa2FyX3hjcmF2YTNDOGQ1UDVjMHI4ak44bUl1bnVoQ3VfSjZGMXR5T19xOWkzaUtSZ2NiMF80bUtvVWU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 88, "total_relevant": 63, "sentiment_summary": {"positive": 12, "negative": 10, "neutral": 41, "score": 50, "total": 63, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 17.95, "count": 32}, {"event": "earnings", "label": "Earnings", "weight": 13.75, "count": 25}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 10}, "market_context": {"has_market_context": true, "latest_close": 2.88, "latest_week": "2026-07-10", "one_week_move": -4.0, "four_week_move": -11.1, "twelve_week_move": -40.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.553915, "market_dynamics_buy_signal": false, "relative_strength": -45.941658, "fair_value_gap": -47.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.3533, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.0% over one week, -11.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 17}, {"label": "Stock Titan", "count": 8}, {"label": "NewMediaWire", "count": 5}, {"label": "TradingKey", "count": 5}, {"label": "dars.gov.et", "count": 3}, {"label": "StockStory", "count": 2}, {"label": "GuruFocus.com", "count": 2}, {"label": "ad-hoc-news.de", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 63}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 32}, {"label": "Earnings", "count": 25}, {"label": "Analyst action", "count": 2}, {"label": "Macro sensitivity", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "63", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.0% over one week, -11.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings"}], "updated_at": "2026-07-18T02:32:01.056785+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}